HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$9.15
Day range
$9.17 - $10.12
Year range
$8.25 - $50.40
Market cap
293.16M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.59M | — |
Operating expense | 39.63M | 160.32% |
Net income | -35.90M | -183.72% |
Net profit margin | -2.26K | — |
Earnings per share | -1.16 | -152.17% |
EBITDA | -38.36M | -152.34% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 292.35M | 39.86% |
Total assets | 305.88M | 42.07% |
Total liabilities | 21.54M | 91.95% |
Total equity | 284.34M | — |
Shares outstanding | 31.35M | — |
Price to book | 1.01 | — |
Return on assets | -37.23% | — |
Return on capital | -40.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -35.90M | -183.72% |
Cash from operations | -33.02M | -263.79% |
Cash from investing | -89.81M | -657.06% |
Cash from financing | 122.62M | 231,249.06% |
Net change in cash | -220.00K | 98.95% |
Free cash flow | -19.63M | -331.92% |
About
Founded
2013
Headquarters
Website
Employees
152
